A generative recommender system with GMM prior for cancer drug generation and sensitivity prediction
Krzysztof Koras, Marcin Mo\.zejko, Paulina Szymczak, Eike Staub, and, Ewa Szczurek

TL;DR
VADEERS is a novel variational autoencoder-based system that generates potential anti-cancer compounds with specific properties and predicts their efficacy against cancer cell lines, integrating drug and cell line data.
Contribution
The paper introduces VADEERS, a semi-supervised GMM prior in a variational autoencoder for simultaneous drug generation and sensitivity prediction, which is a novel approach in this domain.
Findings
Achieved high correlation (r=0.87) between predicted and actual drug sensitivity.
Latent space clusters correspond to drug inhibitory profiles.
Generated compounds reflect known drug property clusters.
Abstract
Recent emergence of high-throughput drug screening assays sparkled an intensive development of machine learning methods, including models for prediction of sensitivity of cancer cell lines to anti-cancer drugs, as well as methods for generation of potential drug candidates. However, a concept of generation of compounds with specific properties and simultaneous modeling of their efficacy against cancer cell lines has not been comprehensively explored. To address this need, we present VADEERS, a Variational Autoencoder-based Drug Efficacy Estimation Recommender System. The generation of compounds is performed by a novel variational autoencoder with a semi-supervised Gaussian Mixture Model (GMM) prior. The prior defines a clustering in the latent space, where the clusters are associated with specific drug properties. In addition, VADEERS is equipped with a cell line autoencoder and a…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsComputational Drug Discovery Methods · Biosimilars and Bioanalytical Methods · Pharmacogenetics and Drug Metabolism
